{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:40:31Z","timestamp":1790127631960,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-025-00831-8","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T15:04:32Z","timestamp":1765551872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Kidney dysfunction in adults living with HIV and HBV: a 10-year retrospective cohort study across seven Asia-Pacific countries"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1304-4059","authenticated-orcid":false,"given":"Thinh Toan","family":"Vu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanushi","family":"Rupasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung Thi Hoai","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Yong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasisopin","family":"Kiertiburanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagalingeswaran","family":"Kumarasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwimon","family":"Khusuwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vohith","family":"Khol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Ketut Agus Somia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Po","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Pujari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchalee","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuong Duy","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awachana","family":"Jiamsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"IeDEA Asia-Pacific","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"11","key":"831_CR1","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/cid\/ciz1170","volume":"71","author":"S Leumi","year":"2020","unstructured":"Leumi S, et al. Global burden of hepatitis B infection in people living with human immunodeficiency virus: A systematic review and meta-analysis. Clin Infect Dis. 2020;71(11):2799\u2013806.","journal-title":"Clin Infect Dis"},{"key":"831_CR2","doi-asserted-by":"publisher","DOI":"10.20517\/2394-5079.2022.32","author":"Q Wan","year":"2022","unstructured":"Wan Q, et al. Hepatocellular carcinoma in hepatitis B and human immunodeficiency virus coinfection in Africa: A focus on surveillance. Hepatoma Res. 2022. https:\/\/doi.org\/10.20517\/2394-5079.2022.32.","journal-title":"Hepatoma Res"},{"issue":"1","key":"831_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.4102\/sajhivmed.v19i1.817","volume":"19","author":"WDF Venter","year":"2018","unstructured":"Venter WDF, Fabian J, Feldman C. An overview of Tenofovir and renal disease for the HIV-treating clinician. South Afr J HIV Med. 2018;19(1):817.","journal-title":"South Afr J HIV Med"},{"issue":"3","key":"831_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/infdis\/jiu107","volume":"210","author":"S Jose","year":"2014","unstructured":"Jose S, et al. Incomplete reversibility of estimated glomerular filtration rate decline following Tenofovir disoproxil fumarate exposure. J Infect Dis. 2014;210(3):363\u201373.","journal-title":"J Infect Dis"},{"issue":"1","key":"831_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12981-019-0227-1","volume":"16","author":"TJ Mtisi","year":"2019","unstructured":"Mtisi TJ, et al. Tenofovir-associated kidney disease in africans: A systematic review. AIDS Res Ther. 2019;16(1):12.","journal-title":"AIDS Res Ther"},{"key":"831_CR6","first-page":"491","volume":"13","author":"SG Debeb","year":"2021","unstructured":"Debeb SG, et al. Tenofovir disoproxil fumarate-associated renal dysfunction among adult people living with HIV at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, 2019: a comparative retrospective cohort study. HIV AIDS (Auckl). 2021;13:491\u2013503.","journal-title":"HIV AIDS (Auckl)"},{"issue":"2","key":"831_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3947\/ic.2023.0001","volume":"55","author":"S Srisopa","year":"2023","unstructured":"Srisopa S, et al. Incidence and risk factors of Tenofovir disoproxil fumarate-induced nephrotoxicity and renal function recovery, a hospital case-control study. Infect Chemother. 2023;55(2):226\u201336.","journal-title":"Infect Chemother"},{"issue":"9","key":"831_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00535-020-01698-4","volume":"55","author":"MR Charlton","year":"2020","unstructured":"Charlton MR, et al. An expert review on the use of Tenofovir Alafenamide for the treatment of chronic hepatitis B virus infection in Asia. J Gastroenterol. 2020;55(9):811\u201323.","journal-title":"J Gastroenterol"},{"issue":"1","key":"831_CR9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1186\/s12879-025-11710-y","volume":"25","author":"E Yunihastuti","year":"2025","unstructured":"Yunihastuti E, et al. Decline in estimated glomerular filtration rate following substitution of Nevirapine-based regimen with Tenofovir-based regimen in Indonesia. BMC Infect Dis. 2025;25(1):1386.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"831_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jinf.2020.04.037","volume":"81","author":"TG Maponga","year":"2020","unstructured":"Maponga TG, et al. Treatment advantage in HBV\/HIV coinfection compared to HBV monoinfection in a South African cohort. J Infect. 2020;81(1):121\u201330.","journal-title":"J Infect"},{"key":"831_CR11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3389\/fphar.2019.01023","volume":"10","author":"T Jiang","year":"2019","unstructured":"Jiang T, et al. Immunological efficacy of tenofovir disproxil fumarate-containing regimens in patients with HIV-HBV coinfection: a systematic review and meta-analysis. Front Pharmacol. 2019;10:1023.","journal-title":"Front Pharmacol"},{"issue":"7","key":"831_CR12","doi-asserted-by":"publisher","first-page":"e68152","DOI":"10.1371\/journal.pone.0068152","volume":"8","author":"H Price","year":"2013","unstructured":"Price H, et al. Suppression of HBV by tenofovir in HBV\/HIV coinfected patients: a systematic review and meta-analysis. PLoS One. 2013;8(7):e68152.","journal-title":"PLoS One"},{"key":"831_CR13","unstructured":"Clinicalinfo. Considerations for Antiretroviral Use in People With Coinfections. 2024 January 9, 2025]; Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/hepatitis-b-virus-hiv-coinfection"},{"issue":"10","key":"831_CR14","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1681\/ASN.2012080857","volume":"24","author":"J Tourret","year":"2013","unstructured":"Tourret J, Deray G, Isnard-Bagnis C. Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword? J Am Soc Nephrol. 2013;24(10):1519\u201327.","journal-title":"J Am Soc Nephrol"},{"key":"831_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-024-03761-1","author":"AJ Ssemasaazi","year":"2024","unstructured":"Ssemasaazi AJ, et al. Higher prevalence of kidney function impairment among older people living with HIV in Uganda. BMC Nephrol. 2024. https:\/\/doi.org\/10.1186\/s12882-024-03761-1.","journal-title":"BMC Nephrol"},{"issue":"1","key":"831_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s44370-024-00005-6","volume":"1","author":"AA Akinola","year":"2024","unstructured":"Akinola AA, et al. Kidney function impairment among adult people living with HIV on antiretroviral therapy in South-West, Nigeria. Discover Viruses. 2024;1(1):5.","journal-title":"Discover Viruses"},{"key":"831_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081254","author":"G Alfano","year":"2019","unstructured":"Alfano G, et al. Kidney disease in HIV infection. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8081254.","journal-title":"J Clin Med"},{"key":"831_CR18","doi-asserted-by":"crossref","unstructured":"V., J., et al., Incidence rate and time to occurrence of renal impairment and chronic kidney disease among Thai HIV-infected adults with Tenofovir disoproxil fumarate use. Open AIDS J, 2021. 15(73\u201380).","DOI":"10.2174\/1874613602115010073"},{"key":"831_CR19","doi-asserted-by":"publisher","first-page":"7650104","DOI":"10.1155\/2020\/7650104","volume":"2020","author":"CQ Hoang","year":"2020","unstructured":"Hoang CQ, et al. Determinants of risk factors for renal impairment among HIV-infected patients treated with Tenofovir disoproxil fumarate-based antiretroviral regimen in Southern Vietnam. Biomed Res Int. 2020;2020:7650104.","journal-title":"Biomed Res Int"},{"issue":"2","key":"831_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jare.2016.07.004","volume":"8","author":"RS Barsoum","year":"2017","unstructured":"Barsoum RS, William EA, Khalil SS. Hepatitis C and kidney disease: a narrative review. J Adv Res. 2017;8(2):113\u201330.","journal-title":"J Adv Res"},{"issue":"2","key":"831_CR21","doi-asserted-by":"publisher","first-page":"e0280339","DOI":"10.1371\/journal.pone.0280339","volume":"18","author":"JE Heron","year":"2023","unstructured":"Heron JE, et al. Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: an observational cohort study. PLoS One. 2023;18(2):e0280339.","journal-title":"PLoS One"},{"key":"831_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2334-14-173","volume":"14","author":"SN Pujari","year":"2014","unstructured":"Pujari SN, et al. Higher risk of renal impairment associated with tenofovir use amongst people living with HIV in India: a comparative cohort analysis between Western India and united Kingdom. BMC Infect Dis. 2014;14:173.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"831_CR23","doi-asserted-by":"publisher","first-page":"e0161562","DOI":"10.1371\/journal.pone.0161562","volume":"11","author":"J Tanuma","year":"2016","unstructured":"Tanuma J, et al. Renal dysfunction during tenofovir use in a regional cohort of HIV-infected individuals in the Asia-Pacific. PLoS One. 2016;11(8):e0161562.","journal-title":"PLoS One"},{"key":"831_CR24","volume-title":"StatPearls","author":"SR Vaidya","year":"2024","unstructured":"Vaidya SR, Aeddula NR. Chronic kidney disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024."},{"key":"831_CR25","unstructured":"Streiner DL. Last observation carried forward. Encyclopedia of research design. SAGE Publications, Inc; 2010. pp. 687\u20138."},{"issue":"4","key":"831_CR26","doi-asserted-by":"publisher","first-page":"e0195443","DOI":"10.1371\/journal.pone.0195443","volume":"13","author":"UE Ekrikpo","year":"2018","unstructured":"Ekrikpo UE, et al. Chronic kidney disease in the global adult HIV-infected population: a systematic review and meta-analysis. PLoS One. 2018;13(4):e0195443.","journal-title":"PLoS One"},{"issue":"1","key":"831_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s41100-019-0245-4","volume":"5","author":"M Ando","year":"2019","unstructured":"Ando M, Ando Y. A high likelihood of increase in end-stage renal disease among the Japanese HIV-infected population. Ren Replace Therapy. 2019;5(1):49.","journal-title":"Ren Replace Therapy"},{"issue":"9","key":"831_CR28","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1097\/01.ASN.0000138546.53152.A7","volume":"15","author":"PW Eggers","year":"2004","unstructured":"Eggers PW, Kimmel PL. Is there an epidemic of HIV infection in the US ESRD program? J Am Soc Nephrol. 2004;15(9):2477\u201385.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"831_CR29","first-page":"27","volume":"65","author":"J Winston","year":"1998","unstructured":"Winston J, Klotman PE. HIV-associated nephropathy. Mt Sinai J Med. 1998;65(1):27\u201332.","journal-title":"Mt Sinai J Med"},{"issue":"8","key":"831_CR30","doi-asserted-by":"publisher","first-page":"e0160626","DOI":"10.1371\/journal.pone.0160626","volume":"11","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, et al. HBV-associated postinfectious acute glomerulonephritis: A report of 10 cases. PLoS One. 2016;11(8):e0160626.","journal-title":"PLoS One"},{"issue":"12","key":"831_CR31","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/cid\/ciu734","volume":"59","author":"A Mweemba","year":"2014","unstructured":"Mweemba A, et al. Chronic hepatitis B virus coinfection is associated with renal impairment among Zambian HIV-infected adults. Clin Infect Dis. 2014;59(12):1757\u201360.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"831_CR32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/s12879-024-09546-z","volume":"24","author":"D Chen","year":"2024","unstructured":"Chen D, et al. Hepatitis B virus infection as a risk factor for chronic kidney disease: A systematic review and meta-analysis. BMC Infect Dis. 2024;24(1):620.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"831_CR33","doi-asserted-by":"publisher","first-page":"e40245","DOI":"10.1371\/journal.pone.0040245","volume":"7","author":"A Mocroft","year":"2012","unstructured":"Mocroft A, et al. Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. PLoS One. 2012;7(7):e40245.","journal-title":"PLoS One"},{"key":"831_CR34","doi-asserted-by":"publisher","first-page":"e3331","DOI":"10.1590\/1518-8345.3553.3331","volume":"28","author":"PS Pontes","year":"2020","unstructured":"Pontes PS, et al. Factors associated to chronic kidney disease in people living with HIV\/AIDS. Rev Lat Am Enfermagem. 2020;28:e3331.","journal-title":"Rev Lat Am Enfermagem"},{"issue":"7","key":"831_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, et al. Chronic kidney disease and the global public health agenda: An international consensus. Nat Rev Nephrol. 2024;20(7):473\u201385.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"831_CR36","doi-asserted-by":"publisher","first-page":"e000256","DOI":"10.1136\/bmjgh-2016-000256","volume":"2","author":"C George","year":"2017","unstructured":"George C, et al. Chronic kidney disease in low-income to middle-income countries: The case for increased screening. BMJ Glob Health. 2017;2(2):e000256.","journal-title":"BMJ Glob Health"},{"issue":"11","key":"831_CR37","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1681\/ASN.0000000000000220","volume":"34","author":"OM Davis","year":"2023","unstructured":"Davis OM, et al. Platelet count and platelet volume in patients with CKD. J Am Soc Nephrol. 2023;34(11):1772\u20135.","journal-title":"J Am Soc Nephrol"},{"key":"831_CR38","doi-asserted-by":"crossref","unstructured":"Gomchok D, Ge RL, Wuren T. Platelets in renal disease. Int J Mol Sci, 2023. 24(19).","DOI":"10.3390\/ijms241914724"},{"issue":"10","key":"831_CR39","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1155\/2014\/532191","volume":"28","author":"VG Gangireddy","year":"2014","unstructured":"Gangireddy VG, et al. Management of thrombocytopenia in advanced liver disease. Can J Gastroenterol Hepatol. 2014;28(10):558\u201364.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"2","key":"831_CR40","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/j.2040-4603.2013.tb00511.x","volume":"3","author":"JD Imig","year":"2013","unstructured":"Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Compr Physiol. 2013;3(2):957\u201376.","journal-title":"Compr Physiol"},{"key":"831_CR41","doi-asserted-by":"publisher","first-page":"1455688","DOI":"10.3389\/fmed.2024.1455688","volume":"11","author":"D Asmelash","year":"2024","unstructured":"Asmelash D, Nigatie M. Chronic kidney disease and its associated factors in HIV-infected individuals: A comparison of antiretroviral therapy na\u00efve and experienced patients. Front Med (Lausanne). 2024;11:1455688.","journal-title":"Front Med (Lausanne)"},{"key":"831_CR42","doi-asserted-by":"publisher","first-page":"212519","DOI":"10.7573\/dic.212519","volume":"7","author":"MM McLaughlin","year":"2018","unstructured":"McLaughlin MM, Guerrero AJ, Merker A. Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV. Drugs Context. 2018;7:212519.","journal-title":"Drugs Context"},{"key":"831_CR43","doi-asserted-by":"crossref","unstructured":"Micali C et al. 1986. Switching to DOR\/3TC\/TDF improves renal function and decreases lipid levels in people living with HIV: A real-life multicentric study. Open Forum Infectious Diseases, 2023. 10(Supplement_2): p. ofad500.113.","DOI":"10.1093\/ofid\/ofad500.113"},{"issue":"9","key":"831_CR44","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1097\/QAD.0000000000002223","volume":"33","author":"SK Gupta","year":"2019","unstructured":"Gupta SK, et al. Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: A pooled analysis of 26 clinical trials. AIDS. 2019;33(9):1455\u201365.","journal-title":"AIDS"},{"issue":"4","key":"831_CR45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/cid\/cis937","volume":"56","author":"C Laprise","year":"2013","unstructured":"Laprise C, et al. Association between Tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up. Clin Infect Dis. 2013;56(4):567\u201375.","journal-title":"Clin Infect Dis"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00831-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-025-00831-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00831-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:33:49Z","timestamp":1769834029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12981-025-00831-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1186\/s12981-025-00831-8","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for the study was obtained from the ethics committees of each participating site, the data management and biostatistical center at the Kirby Institute [The University of New South Wales (UNSW) Human Ethics committee], and the coordinating center at TREAT Asia\/amfAR. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}